Vocal Biomarkers Market By Therapeutic Applications (Psychiatric Disorders, Parkinson’s Disease, Cognitive Impairment, Brain Trauma Injury, Respiratory Disorders, Cardiovascular Disorders and Others), By End user (Hospitals, Health Insurers, Academic Institutes, and Government Organizations) and By Region - Trends, Analysis and Forecast till 2034

The market for vocal biomarkers was valued at US$ 1.65 billion in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 14.1% to reach US$ 6.18 billion by 2030. The Global Vocal Biomarker Market is divided into five regions: Latin America, North America, Europe, Asia Pacific, and the Middle East and Africa. North America holds a significant market share in the vocal biomarkers industry due to its technological and medical advancements. In addition to health, the demand for vocal biomarkers in the defense industry is being driven by the heightened emphasis on national security and the goal of retaining the country's position as a global powerhouse. Europe is also essential to the global voice biomarker market. The anticipated rise in demand from Asia Pacific draws in current players. The marketplace for vocal biomarkers will rise as countries like India and China improve their defence and healthcare systems.